Top Markets
Coin of the day
Aida Pharmaceuticals, Inc. Aida Pharmaceuticals, Inc.

Aida Pharmaceuticals, Inc.

AIDA
Rank in Stocks #41891
Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively... Aida Pharmaceuticals, Inc., together with its affiliates, operates extensively throughout mainland China, specializing in the entire spectrum of pharmaceutical and genetic product development. This encompasses formulation, clinical trials, regulatory registration, manufacturing, sales, and marketing. The company's diverse product range includes antibiotics, cardiovascular medicines, and anti-cancer drugs. These are available in various forms, such as injectable powders, intravenous liquids, capsules, tablets, and ointments. Notable products feature Etimicin Sulfate, provided as an injectable powder, and rh-Apo2l, a biopharmaceutical therapy targeting cancers. Established in 1999, Aida Pharmaceuticals, Inc. is headquartered in Hangzhou, China.
Share Price
$0.0003
Last synced: 2026-08-11
Market Cap
$8.10K
Change (1 day)
0.00%
Change (1 year)
50.00%
Country
CN
Trade Aida Pharmaceuticals, Inc. (AIDA)

Category

P/B ratio for Aida Pharmaceuticals, Inc. (AIDA)
P/B ratio as of 2026 TTM: 0
According to Aida Pharmaceuticals, Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Aida Pharmaceuticals, Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors